Clinical effect of a topical herbal ointment on pain in temporomandibular disorders: A randomized placebo-controlled trial

Journal of Alternative and Complementary Medicine

Volumn 15, Issue 12, 2009, Pages 1311-1317

  Li, Larry C F ^a   Wong, Ricky W K ^a   Rabie, A Bakr M ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CHINESE DRUG; PETROLATUM; PING ON; PLACEBO; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROL GROUP; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; EYE IRRITATION; FEMALE; HUMAN; JAW DISEASE; MAJOR CLINICAL STUDY; MALE; MASTICATORY MUSCLE; MYOFASCIAL PAIN; OINTMENT; PAIN ASSESSMENT; PRIORITY JOURNAL; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SKIN BURNING SENSATION; TREATMENT DURATION; VISUAL ANALOG SCALE;

ADMINISTRATION, TOPICAL; ADULT; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MALE; MASTICATORY MUSCLES; MIDDLE AGED; OINTMENTS; PAIN; TEMPOROMANDIBULAR JOINT; TEMPOROMANDIBULAR JOINT DISORDERS;

EID: 73149085535     PISSN: 10755535     EISSN: None     Source Type: Journal    
DOI: 10.1089/acm.2009.0129     Document Type: Article

References (38)

1. National Institutes of Health Technology Assessment Conference on Management of Temporomandibular Disorders. Bethesda, Maryland, April 29-May 1, 1996. Proceedings. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83:49-50.
2. Ta LE, Dionne RA. Treatment of painful temporomandibular joints with a cyclooxygenase-2 inhibitor: A randomized placebo-controlled comparison of celecoxib to naproxen. Pain 2004;111:13-21.
3. Rugh JD, Solberg WK. Oral health status in the United States: Temporomandibular disorders. J Dent Educ 1985;49:398-406.
4. Antczak-Bouckoms A. Reaction paper to chapter 12 and 13. In: Sessle BJ, Bryant PS, Dionne RA, eds. Temporomandibular disorders and related pain conditions, Seattle, WA: IASP Press, 1995:237-245.
5. Dionne RA. Pharmacologic treatments for temporomandibular disorders. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83:134-142.
6. List T, Axelsson S, Leijon G. Pharmacologic interventions in the treatment of temporomandibular disorders, atypical facial pain, and burning mouth syndrome: A qualitative systematic review. J Orofac Pain 2003;17:301-310.
7. Winocur E, Gavish A, Halachmi M, et al. Topical application of capsaicin for the treatment of localized pain in the temporomandibular joint area. J Orofac Pain 2000;14:31-36.
8. Lobo SL, Mehta N, Forgione AG, et al. Use of Theraflex-TMJ topical cream for the treatment of temporomandibular joint and muscle pain. J Craniomandib Pract 2004;22:137-144.
9. Svensson P, Houe L, Arendt-Nielsen L. Effect of systemic versus topical nonsteroidal anti-inflammatory drugs on postexercise jaw-muscle soreness: A placebo-controlled study. J Orofac Pain 1997;11:353-362.
10. Shin SM, Choi JK. Effect of indomethacin phonophoresis on the relief of temporomandibular joint pain. Cranio 1997; 15:345-348.
11. Wong RWK, Rabie ABM. Local message with topical analgesic, a novel treatment modality for temporomandibular muscular pain, a case study report of 5 consecutive cases. Open Orthop J 2008;2:97-102.
12. Dworkin SF, LeResche L. Research diagnostic criteria for temporomandibular disorders: Review, criteria, examinations and specifications, critique. J Craniomandib Disord 1992;6: 301-355.
13. Moher D, Schulz KF, Altman DG. The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357: 1191-1194. (Pubitemid 32378696)
14. Cohen M, Wolfe R, Mai T, Lewis D. A randomized, double blind, placebo controlled trial of a topical cream containing glucosamine sulfate, chondroitin sulfate, and camphor for osteoarthritis of the knee. J Rheumatol 2003;30:523-528.
15. Wright EF, Schiffman EL. Treatment alternatives for patients with masticatory myofascial pain. J Am Dent Assoc 1995; 126:1030-1039.
16. Simon LS, Lanza FL, Lipsky PE, et al. Preliminary study of the safety and efficacy of SC-58635, a novel cyclooxygenase 2 inhibitor: Efficacy and safety in two placebo-controlled trials in osteoarthritis and rheumatoid arthritis, and studies of gastrointestinal and platelet effects. Arthritis Rheum 1998;41: 1591-1602.
17. Turk DC, Rudy TE, Sorkin BA. Neglected topics in chronic pain treatment outcome studies: Determination of success. Pain 1993;57:253-254.
18. Silva J, Abebe W, Sousa SM, et al. Analgesic and antiinflammatory effects of essential oils of eucalyptus. J Ethnopharmacol 2003;89:277-283.
19. Chan TY. Potential dangers from topical preparations containing methyl salicylate. Hum Exp Toxicol 1996;15:747-750.
20. Golder W. Propolis. The bee glue as presented by the Graeco- Roman literature. Wurzbg Medizinhist Mitt 2004;23:133-145.
21. Park EH, Kahng JH. Suppressive effects of propolis in rat adjuvant arthritis. Arch Pharm Res 1999;22:554-558.
22. Kligler B, Chaudhary S. Peppermint oil. Am Fam Physician 2007;75:1027-1030.
23. Goöbel H, Fresenius J, Heinze A. Effectiveness of Oleum menthae piperitae and paracetamol in therapy of headache of the tension type. Nervenarzt 1996;67:672-681.
24. Patel T, Ishiuji Y, Yosipovitch G. Menthol:Arefreshing look at this ancient compound. JAmAcad Dermatol 2007;57:873-878.
25. Cliff MA, Green BG. Sensory irritation and coolness produced by menthol: Evidence for selective desensitization of irritation. Physiol Behav 1994;56:1021-1029.
26. Macpherson LJ, Dubin AE, Evans MJ, et al. Noxious compounds activate TRPA1 ion channels through covalent modification of cysteines. Nature 2007;445:541-545.
27. Galeotti N, Di Cesare, Mannelli L, et al. Menthol: A natural analgesic compound. Neurosci Lett 2002;322:145-148.
28. Yener G, GönüllüU, Uner M, et al. Effect of vehicles and penetration enhancers on the in vitro percutaneous absorption of celecoxib through human skin. Pharmazie 2003;58: 330-333.
29. Xu H, Blair NT, Clapham DE. Camphor activates and strongly desensitizes the transient receptor potential vanilloid subtype 1 channel in a vanilloid-independent mechanism. J Neurosci 2005;25:8924-8937.
30. Dyszkiewicz A, Opara J. Monitoring the treatment of low back pain using non-steroid anti-inflammatory drugs and aromatic oil components. Ortop Traumatol Rehabil 2006; 8:210-218.
31. Lin HB. Using Traditional Chinese Medicine for treating temporomandibular disorders [in Chinese]. Chin J Tradit West Med 2003;6.
32. Ye YY, Jiang Y, Ma XQ. Professor Zhu Liangchun's experience in differentiating and treating Bi-syndromes. Shanghai J Tradit Chin Med 2003;9.
33. Ke N-m, Ke H, Wang X-y. Treatment of BI syndrome with TCM method and compared the clinical effect and utilization of commonly used governs the Bi syndrome Chinese herb medicine. Chin Arch Tradit Chin Med 2007;1.
34. Zuo YF, Tang DC, Xuan JY, et al. Science of Chinese materia medica. Shanghai, PRC: Publishing house of Shanghai University of Traditional Chinese Medicine, 2003:57.
35. Nan Jing Chinese Medicine University, Traditional Chinese Medicine Dictionary [in Chinese]. Shanghai: Publishing House of Shanghai Science and Technology, 2006.
36. Smith P, Mosscrop D, Davies S, et al. The efficacy of acupuncture in the treatment of temporomandibular joint myofascial pain: A randomised controlled trial. J Dent 2007;35: 259-267.
37. Kropmans TJ, Dijkstra PU, Stegenga B, et al. Smallest detectable difference in outcome variables related to painful restriction of the temporomandibular joint. J Dent Res 1999; 78:784-789.
38. Kropmans T, Dijkstra P, Stegenga B, et al. Smallest detectable difference of maximal mouth opening in patients with painfully restricted temporomandibular joint function. Eur J Oral Sci 2000;108:9-13.